GEN Exclusives

More »

GEN News Highlights

Back to Item »

Hydra and Cubist Ally to Further Ion Channel Drugs for Pain Management

Cubist is paying $5 million up front and $5 million in R&D funding to advance preclinical candidates.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Sustainability in New Dietary Guidelines

Do you think that sustainability considerations should be incorporated into the new Dietary Guidelines for Americans?

More »